|
|
|
|
Fibrogen Inc (NASDAQ: FGEN) |
|
|
|
| |
Fibrogen Inc 's Leverage Ratio
FGEN's quarterly Leverage Ratio and Total Liabilities, Equity growth
In Q1 2025 Fibrogen Inc had stockholder deficit.
Within Major Pharmaceutical Preparations industry Fibrogen Inc achieved the lowest Leverage Ratio in the first quarter 2025. While total ranking remained the same in the first quarter 2025 compared to the previous quarter at no. .
Explain Leverage Ratio?
How much Total Liabilitiess FGEN´s has?
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| FGEN Leverage Ratio |
(Mar 31 2025)
Q1 |
(Dec 31 2024)
Q4 |
(Sep 30 2024)
Q3 |
(Jun 30 2024)
Q2 |
(Mar 31 2024)
Q1 |
| Y / Y Equity Change |
- |
- |
- |
- |
- |
| Y / Y Total Liabilities Change |
-36.95 % |
-30.89 % |
-18.34 % |
-15.39 % |
-2.37 % |
| Leverage Ratio MRQ |
- |
- |
- |
- |
- |
| FGEN's Total
Ranking |
# |
# |
# |
# |
# |
| Seq. Equity Change |
- |
- |
- |
- |
- |
| Seq. Total Liabilities Change |
-13.83 % |
-13.94 % |
-3.46 % |
-11.93 % |
-5.55 % |
| Leverage Ratio first quarter 2025 Company Ranking |
| Within: |
No. |
| Major Pharmaceutical Preparations Industry |
# |
| Healthcare Sector |
# |
| Overall Market |
# |
| Leverage Ratio Statistics |
| High |
Average |
Low |
| 0 |
0 |
0 |
|
|
|
Cumulative Fibrogen Inc 's Leverage Ratio
FGEN's Leverage Ratio for the trailling 12 Months
FGEN Leverage Ratio |
(Mar 31 2025)
12 Months |
(Dec 31 2024)
12 Months |
(Sep 30 2024)
12 Months |
(Jun 30 2024)
12 Months |
(Mar 31 2024)
12 Months |
| Y / Y Equity TTM Growth |
- |
- |
- |
- |
- |
| Y / Y Total Liabilities TTM Growth |
-25.3 % |
-16.86 % |
-9.93 % |
-4.82 % |
-0.41 % |
| Leverage Ratio TTM |
- |
- |
- |
- |
- |
| Total Ranking TTM |
|
|
|
|
|
| Seq. Equity TTM Growth |
- |
- |
- |
- |
- |
| Seq. Total Liabilities TTM Growth |
-10.67 % |
-8.63 % |
-4.8 % |
-3.87 % |
-0.58 % |
On the trailing twelve months basis During the 12 months period ending Q1 2025 company had stockholder deficit. Leverage Ratio is the average cumulative value over the last four quarters.
Among companies in the Major Pharmaceutical Preparations industry FGEN recorded the lowest Leverage Ratio. While total ranking remained unchanged compared to previous 12 month period at no. 0.
Explain Leverage Ratio?
How much Total Liabilitiess FGEN´s has?
| TTM Leverage Ratio Company Ranking |
| Within: |
No. |
| Within the Major Pharmaceutical Preparations Industry |
# |
| Healthcare Sector |
# |
| Within the Market |
# |
| trailing twelve months Leverage Ratio Statistics |
| High |
Average |
Low |
| 0 |
0 |
0 | |
|
|
| Companies with similar Leverage Ratio in the quarter ending Mar 31 2025, within Major Pharmaceutical Preparations Industry | Leverage Ratio | Mar 31 2025 MRQ Total Liabilities | Mar 31 2025 MRQ Equity |
|
Date modified: 2025-05-15T04:07:47+00:00
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
